Ginkgo biloba shows real biological activity related to diabetes, but it does not directly lower blood sugar or HbA1c in human studies. A 2024 meta-analysis in Frontiers in Endocrinology found no difference between ginkgo and placebo for fasting blood glucose or HbA1c in people with type 2 diabetes. Where ginkgo may offer value is in protecting against some of the complications diabetes causes, particularly nerve damage and early kidney disease.
What Ginkgo Does Inside the Body
In animal and cell studies, ginkgo extract triggers several changes relevant to diabetes. It appears to boost insulin production by stimulating pancreatic beta cells, the cells responsible for making insulin. In obese rats fed a high-fat diet, ginkgo treatment produced a threefold increase in fasting insulin levels compared to normal-diet controls. It also improved insulin signaling in muscle tissue: a key step in how muscles absorb glucose from the blood improved by over 400%, while a protein that blocks insulin signaling dropped by about 52%.
Ginkgo also seems to protect the insulin-producing cells themselves. In a study on diabetic rats, four weeks of ginkgo extract increased beta-cell mass and insulin production while improving antioxidant defenses in pancreatic tissue. This matters because type 2 diabetes progressively destroys beta cells over time, and anything that slows that process could theoretically slow the disease.
The problem is that these promising biological effects haven’t translated into measurable blood sugar improvements in humans.
The Human Evidence on Blood Sugar Control
When researchers pooled results from human clinical trials, ginkgo did not reduce HbA1c (the three-month average blood sugar marker) or fasting blood glucose compared to placebo. It also showed no effect on cholesterol or triglyceride levels. One smaller study did find a modest HbA1c reduction, from 7.7% to 7.2%, in people with type 2 diabetes taking 120 mg of standardized ginkgo extract daily. But this was a secondary finding in a drug interaction study, not a dedicated blood sugar trial, and the larger meta-analysis didn’t confirm the effect.
In short, if you’re looking for a supplement to bring your blood sugar numbers down, ginkgo biloba is not a reliable tool for that purpose.
Where Ginkgo May Actually Help: Nerve Damage
Diabetic neuropathy, the tingling, numbness, and pain that develops in the feet and hands of many people with diabetes, is one area where ginkgo shows more consistent promise. In a clinical trial of 156 patients, taking 120 mg per day of standardized ginkgo extract for six months produced a noticeable reduction in pain intensity and improved sense of touch. The effect appears to be dose-dependent: higher doses produce stronger pain relief.
In a head-to-head comparison, ginkgo combined with a B-vitamin supplement outperformed placebo in reducing physical symptoms and improving nerve function. Animal studies back this up, showing that ginkgo reduces pain responses to both cold and pressure stimuli in models of nerve damage. Ginkgo’s combination of antioxidant activity, improved blood flow, and anti-inflammatory effects likely all contribute to these results.
Potential Benefits for Kidney Disease
Early diabetic kidney disease is another complication where ginkgo has shown some activity. High blood sugar gradually damages the tiny blood vessels in the kidneys, eventually causing protein to leak into the urine, a sign of declining kidney function. In animal models, ginkgo reversed increases in urinary protein, blood urea nitrogen, and creatinine, all markers of kidney stress. It also improved the physical structure of kidney tissue under microscopic examination.
A randomized, double-blind trial in humans found that ginkgo slowed the worsening of albumin leakage in people with type 2 diabetes and early kidney disease. This suggests ginkgo could serve as a protective agent in the early stages of diabetic kidney damage, though it’s not a replacement for blood pressure and blood sugar management, which remain the primary strategies for preserving kidney function.
Safety and Drug Interactions
Ginkgo’s most significant risk is bleeding. It inhibits platelet function, which means it can increase the likelihood of bruising or more serious bleeding events, including rare cases of intracranial bleeding. This risk climbs significantly if you’re also taking blood thinners like warfarin or direct oral anticoagulants, antiplatelet drugs like clopidogrel or aspirin, or common pain relievers like ibuprofen, celecoxib, or other NSAIDs. If you take any of these, ginkgo is not a safe addition without medical guidance.
Mild side effects can include headache, heart palpitations, digestive upset, constipation, and skin reactions.
For people taking metformin, the news is more reassuring. A controlled crossover study found that 120 mg of ginkgo extract taken alongside 500 mg of metformin did not significantly change how metformin was absorbed or processed by the body. The only notable change was a slight increase in how long metformin stayed in the system, which was not clinically meaningful. So ginkgo and metformin don’t appear to interfere with each other at standard doses, though the interaction hasn’t been studied across all possible dosing combinations.
What This Means Practically
Ginkgo biloba is not a blood sugar supplement. If you’re hoping it will lower your glucose readings or replace any part of your diabetes management, the human evidence simply doesn’t support that. Where it may earn a role is as a complementary option for managing specific diabetes complications, particularly neuropathic pain and possibly early kidney damage, where the evidence is more encouraging.
Most clinical research uses standardized extract (known as EGb 761) at doses of 120 mg per day. Unstandardized products vary widely in their active compound concentration, so the extract formulation matters. The standardized version contains consistent levels of the flavonoids and terpenoids thought to be responsible for ginkgo’s biological effects.